SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Washington cannabis industry joins vaccine push with ‘joints for jabs’

    By

    Policymakers have long been concerned it might be harder to convince young people who are less likely to fear serious illness from Covid-19 to get the vaccine.

    One US state has come up with a novel idea to get round that problem: joints for jabs.

    Washington is allowing pre-rolled cannabis joints to be handed out to people turning up to get their first or second dose.

    It’s hoped the policy will coax reluctant or nervous adults to vaccine centres as the state looks to drive up its inoculation rates.

    Washington was among the first states to legalise recreational cannabis use.

    Washington set itself a target of reaching 70% protection before the planned lifting of restriction on June 30 – but the state isn’t quite there yet.

    According to health department data, the 63.88% of people older than 16 have ‘initiated vaccination’ as of June 7.

    The announcement by the state’s liquor and cannabis board that dispensaries can hand out incentives came after Washington’s cannabis industry actively sought to get involved in an initiative launched by the drinks industry.

    Vaccinated people have been able to get a free beer or cocktail at many bars in the state since mid-May.

    The joints for jabs scheme can be access by anyone aged 21 or older and runs until mid-July.

    Recreational cannabis use has been legal in Washington since 2012 when it became one of the first states to liberalise drug laws.

    On June, the federal government changed rules give states access to relief funds in order to cover the costs of programmes designed to incentivise vaccine uptake.

    [activecampaign form=31]

    Sean Seddon

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free